Search
EMA Guidance: SEPA Direct Debit B2B for Applicants and Marketing Authorisation Holders
The European Medicines Agency (EMA) has issued guidance explaining how applicants and marketing authorisation holders can use SEPA Direct Debit Business-to-Business (B2B) to pay certain EMA fees. The guidance, dated 20 August 2026, covers mandate setup, payment collection, returned transactions, withdrawals and related requirements. Single Euro Payments Area framework (SEPA) Direct Debit B2B allows EMA to collect euro-denominated payments from business debtors using a signed
Sharan Murugan
19 hours ago3 min read